Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Spicer

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Frontiers in Immunology|April 4, 2019
Combining Immune Checkpoint Inhibitors: Established and Emerging Targets and Strategies to Improve Outcomes in MelanomaDuaa O Khair, Heather J Bax, Silvia Mele, et al.
Allergy|April 15, 2018
An immunologically relevant rodent model demonstrates safety of therapy using a tumour-specific IgED H Josephs, M Nakamura, H J Bax, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2018
Anti-Folate Receptor Alpha-Directed Antibody Therapies Restrict the Growth of Triple-negative Breast CancerAnthony Cheung, James Opzoomer, Kristina M Ilieva, et al.
Cancer Research|July 5, 2021
Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast CancerRobert J Harris, Anthony Cheung, Joseph C F Ng, et al.
Allergy|December 30, 2016
AllergoOncology - the impact of allergy in oncology: EAACI position paperE Jensen-Jarolim, H J Bax, R Bianchini, et al.
Cancer Research|January 19, 2017
Anti-Folate Receptor-α IgE but not IgG Recruits Macrophages to Attack Tumors via TNFα/MCP-1 SignalingDebra H Josephs, Heather J Bax, Tihomir Dodev, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Frontiers in Immunology|April 4, 2019
Combining Immune Checkpoint Inhibitors: Established and Emerging Targets and Strategies to Improve Outcomes in MelanomaDuaa O Khair, Heather J Bax, Silvia Mele, et al.
Allergy|April 15, 2018
An immunologically relevant rodent model demonstrates safety of therapy using a tumour-specific IgED H Josephs, M Nakamura, H J Bax, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2018
Anti-Folate Receptor Alpha-Directed Antibody Therapies Restrict the Growth of Triple-negative Breast CancerAnthony Cheung, James Opzoomer, Kristina M Ilieva, et al.
Cancer Research|July 5, 2021
Tumor-Infiltrating B Lymphocyte Profiling Identifies IgG-Biased, Clonally Expanded Prognostic Phenotypes in Triple-Negative Breast CancerRobert J Harris, Anthony Cheung, Joseph C F Ng, et al.
Allergy|December 30, 2016
AllergoOncology - the impact of allergy in oncology: EAACI position paperE Jensen-Jarolim, H J Bax, R Bianchini, et al.
Cancer Research|January 19, 2017
Anti-Folate Receptor-α IgE but not IgG Recruits Macrophages to Attack Tumors via TNFα/MCP-1 SignalingDebra H Josephs, Heather J Bax, Tihomir Dodev, et al.
Pageof 8